Cell and molecular biology of transthyretin and thyroid hormones

被引:87
作者
Richardson, Samantha J. [1 ]
机构
[1] Museum Natl Histoire Nat, UMR 5166, CNRS, Evolut Regulat Endocriniennes, F-75231 Paris, France
来源
INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 258 | 2007年 / 258卷
关键词
brain; choroid plexus; development; disease; liver; nonvertebrates; protein evolution; thyroid hormones; transthyretin;
D O I
10.1016/S0074-7696(07)58003-4
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Advances in four areas of transthyretin (TTR) research result in this being a timely review. Developmental studies have revealed that TTR is synthesized in all classes of vertebrates during development. This leads to a new hypothesis on selection pressure for hepatic TTR synthesis during development only, changing the previous hypotheses from "onset" of hepatic TTR synthesis in adulthood to "maintaining" hepatic TTR synthesis into adulthood. Evolutionary studies have revealed the existence of TTR-like proteins (TLPs) in nonvertebrate species and elucidated some of their functions. Consequently, TTR is an excellent model for the study of the evolution of protein structure, function, and localization. Studies of human diseases have demonstrated that TTR in the cerebrospinal fluid can form amyloid, but more recently there has been recognition of the roles of TTR in depression and Alzheimer's disease. Furthermore, amyloid mutations in human TTR that are the normal residues in other species result in cardiac deposition of TTR amyloid in humans. Finally, a revised model for TTR-thyroxine entry into the cerebrospinal fluid via the choroid plexus, based on data from studies in TTR null mice, is presented. This review concentrates on TTR and its thyroid hormone binding, in development and during evolution, and summarizes what is currently known about TLPs and the role of TTR in diseases affecting the brain.
引用
收藏
页码:137 / 193
页数:57
相关论文
共 176 条
[1]   TRANSTHYRETIN GENE-EXPRESSION IN CHOROID-PLEXUS 1ST EVOLVED IN REPTILES [J].
ACHEN, MG ;
DUAN, W ;
PETTERSSON, TM ;
HARMS, PJ ;
RICHARDSON, SJ ;
LAWRENCE, MC ;
WETTENHALL, REH ;
ALDRED, AR ;
SCHREIBER, G .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (05) :R982-R989
[2]  
ACHEN MG, 1992, J BIOL CHEM, V267, P23170
[3]   Evolution of shorter and more hydrophilic transthyretin N-termini by stepwise conversion of exon 2 into intron 1 sequences (shifting the 3' splice site of intron 1) [J].
Aldred, AR ;
Prapunpoj, P ;
Schreiber, G .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 246 (02) :401-409
[4]  
Almeida M. R., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P587, DOI 10.2174/156800705774322076
[5]   Liver transplantation and new therapeutic approaches for familial amyloidotic polyneuropathy (FAP) [J].
Yukio Ando .
Medical Molecular Morphology, 2005, 38 (3) :142-154
[6]   Ostertag revisited: The inherited systemic amyloidoses without neuropathy [J].
Benson, MD .
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2005, 12 (02) :75-87
[7]   Re-evaluation of the thyroxine binding to human plasma lipoproteins using three techniques [J].
Benvenga, S ;
Lapa, D ;
Trimarchi, F .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2001, 24 (05) :RC16-RC18
[8]   Perspectives in the study of thyroid hormone action on brain development and function [J].
Bernal, J ;
Guadaño-Ferraz, A ;
Morte, B .
THYROID, 2003, 13 (11) :1005-1012
[9]   Binding of biliverdin, bilirubin, and thyroid hormones to lipocalin-type prostaglandin D synthase [J].
Beuckmann, CT ;
Aoyagi, M ;
Okazaki, I ;
Hiroike, T ;
Toh, H ;
Hayaishi, O ;
Urade, Y .
BIOCHEMISTRY, 1999, 38 (25) :8006-8013
[10]   STRUCTURE OF HUMAN PLASMA PREALBUMIN AT 2.5 A RESOLUTION - PRELIMINARY REPORT ON POLYPEPTIDE-CHAIN CONFORMATION, QUATERNARY STRUCTURE AND THYROXINE BINDING [J].
BLAKE, CCF ;
GEISOW, MJ ;
SWAN, IDA .
JOURNAL OF MOLECULAR BIOLOGY, 1974, 88 (01) :1-&